Follow the people · Insider
B. Lynne Parshall
B. Lynne Parshall files insider transactions with the SEC as a director of Cytokinetics (CYTK). We hold 5 disclosed purchases and sales filed since 4 January 2006, 1 of them in the last 90 days.
- Files forCYTK
- Disclosed buys and sells5 in all, 1 in the last 90 days
- Last disclosure1 September 2026
Positions held
9 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 7 February 2013 — 1 September 2026Director · Cytokinetics (CYTK)101 Form 4 lines · source: SEC Form 4
- Filed 16 August 2022 — 24 June 2026Director · Foghorn Therapeutics (FHTX)5 Form 4 lines · source: SEC Form 4
- Filed 1 January 2016 — 15 April 2026COO · Ionis Pharmaceuticals (IONS)163 Form 4 lines · source: SEC Form 4
- Filed 7 May 2018 — 12 October 2020Director · Akcea Therapeutics (AKCA)5 Form 4 lines · source: SEC Form 4
- Filed 1 January 2006 — 9 November 2015COO & Secretary · Isis Pharmaceuticals (ISIS)404 Form 4 lines · source: SEC Form 4
- Filed 10 October 2012 — 26 September 2014Director and 10% owner · Regulus Therapeutics (RGLS)6 Form 4 lines · source: SEC Form 4
- Filed 25 June 2014 — 22 August 2014Director and 10% owner · Regulus Therapeutics ("""RGLS""")9 Form 4 lines · source: SEC Form 4
- Filed 20 July 2006 — 14 August 2009Director · Cardiodynamics International (CDIC)10 Form 4 lines · source: SEC Form 4
- Filed 11 May 2006 — 11 May 2006Director · Corautus Genetics (VEGF)1 Form 4 line · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 1,715 shares of Ionis PharmaceuticalsSEC Form 419 January 2016Common Stock · traded 15 January 2016 · filed 19 January 2016
- ▼ sold on the open market 667 shares of Ionis PharmaceuticalsSEC Form 419 January 2016Common Stock · traded 19 January 2016 · filed 19 January 2016
- exercised options over 2,595 shares of Ionis PharmaceuticalsSEC Form 419 January 2016Common Stock · traded 15 January 2016 · filed 19 January 2016
- ▼ sold on the open market 1,003 shares of Ionis PharmaceuticalsSEC Form 419 January 2016Common Stock · traded 19 January 2016 · filed 19 January 2016
- exercised options over 3,438 shares of Ionis PharmaceuticalsSEC Form 419 January 2016Common Stock · traded 15 January 2016 · filed 19 January 2016
- ▼ sold on the open market 1,219 shares of Ionis PharmaceuticalsSEC Form 419 January 2016Common Stock · traded 19 January 2016 · filed 19 January 2016
- acquired or disposed of, other 72 shares of Ionis PharmaceuticalsSEC Form 44 January 2016Common Stock · traded 1 January 2016 · filed 4 January 2016
- exercised options over 809 shares of Ionis PharmaceuticalsSEC Form 44 January 2016Common Stock · traded 4 January 2016 · filed 4 January 2016
- ▼ sold on the open market 809 shares of Ionis PharmaceuticalsSEC Form 44 January 2016Common Stock · traded 4 January 2016 · filed 4 January 2016
- was granted 107,549 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 44 January 2016Employee Stock Option (right to buy) · traded 4 January 2016 · filed 4 January 2016
- exercised options over 809 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 44 January 2016Employee Stock Option (right to buy) · traded 4 January 2016 · filed 4 January 2016
- gave away 4,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 49 November 2015Employee Stock Option (right to buy) · traded 9 November 2015 · filed 9 November 2015
- gave away 1,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 49 November 2015Employee Stock Option (right to buy) · traded 9 November 2015 · filed 9 November 2015
- gave away 1,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 49 November 2015Employee Stock Option (right to buy) · traded 9 November 2015 · filed 9 November 2015
- gave away 1,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 49 November 2015Employee Stock Option (right to buy) · traded 9 November 2015 · filed 9 November 2015
- gave away 1,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 49 November 2015Employee Stock Option (right to buy) · traded 9 November 2015 · filed 9 November 2015
- exercised options over 4,162 shares of Isis PharmaceuticalsSEC Form 45 October 2015Common Stock · traded 1 October 2015 · filed 5 October 2015
- ▼ sold on the open market 4,162 shares of Isis PharmaceuticalsSEC Form 45 October 2015Common Stock · traded 1 October 2015 · filed 5 October 2015
- exercised options over 2,838 shares of Isis PharmaceuticalsSEC Form 45 October 2015Common Stock · traded 1 October 2015 · filed 5 October 2015
- ▼ sold on the open market 2,838 shares of Isis PharmaceuticalsSEC Form 45 October 2015Common Stock · traded 1 October 2015 · filed 5 October 2015
- exercised options over 2,000 shares of Isis PharmaceuticalsSEC Form 45 October 2015Common Stock · traded 2 October 2015 · filed 5 October 2015
- ▼ sold on the open market 2,000 shares of Isis PharmaceuticalsSEC Form 45 October 2015Common Stock · traded 2 October 2015 · filed 5 October 2015
- exercised options over 3,436 shares of Isis PharmaceuticalsSEC Form 45 October 2015Common Stock · traded 2 October 2015 · filed 5 October 2015
- ▼ sold on the open market 3,436 shares of Isis PharmaceuticalsSEC Form 45 October 2015Common Stock · traded 2 October 2015 · filed 5 October 2015
- exercised options over 4,162 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 45 October 2015Employee Stock Option (right to buy) · traded 1 October 2015 · filed 5 October 2015
- exercised options over 2,838 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 45 October 2015Employee Stock Option (right to buy) · traded 1 October 2015 · filed 5 October 2015
- exercised options over 5,436 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 45 October 2015Employee Stock Option (right to buy) · traded 2 October 2015 · filed 5 October 2015
- exercised options over 1,375 shares of Isis PharmaceuticalsSEC Form 48 July 2015Common Stock · traded 6 July 2015 · filed 8 July 2015
- ▼ sold on the open market 1,375 shares of Isis PharmaceuticalsSEC Form 48 July 2015Common Stock · traded 6 July 2015 · filed 8 July 2015
- exercised options over 4,843 shares of Isis PharmaceuticalsSEC Form 48 July 2015Common Stock · traded 6 July 2015 · filed 8 July 2015
- ▼ sold on the open market 4,843 shares of Isis PharmaceuticalsSEC Form 48 July 2015Common Stock · traded 6 July 2015 · filed 8 July 2015
- exercised options over 1,375 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 48 July 2015Employee Stock Option (right to buy) · traded 6 July 2015 · filed 8 July 2015
- exercised options over 4,843 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 48 July 2015Employee Stock Option (right to buy) · traded 6 July 2015 · filed 8 July 2015
- acquired or disposed of, other 71 shares of Isis PharmaceuticalsSEC Form 42 July 2015Common Stock · traded 1 July 2015 · filed 2 July 2015
- exercised options over 6,218 shares of Isis PharmaceuticalsSEC Form 42 July 2015Common Stock · traded 1 July 2015 · filed 2 July 2015
- ▼ sold on the open market 6,218 shares of Isis PharmaceuticalsSEC Form 42 July 2015Common Stock · traded 1 July 2015 · filed 2 July 2015
- exercised options over 6,218 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 42 July 2015Employee Stock Option (right to buy) · traded 1 July 2015 · filed 2 July 2015
- exercised options over 5,565 shares of Isis PharmaceuticalsSEC Form 48 April 2015Common Stock · traded 7 April 2015 · filed 8 April 2015
- ▼ sold on the open market 5,565 shares of Isis PharmaceuticalsSEC Form 48 April 2015Common Stock · traded 7 April 2015 · filed 8 April 2015
- exercised options over 5,565 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 48 April 2015Employee Stock Option (right to buy) · traded 7 April 2015 · filed 8 April 2015
- exercised options over 5,377 shares of Isis PharmaceuticalsSEC Form 46 April 2015Common Stock · traded 1 April 2015 · filed 6 April 2015
- ▼ sold on the open market 5,377 shares of Isis PharmaceuticalsSEC Form 46 April 2015Common Stock · traded 1 April 2015 · filed 6 April 2015
- exercised options over 5,377 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 46 April 2015Employee Stock Option (right to buy) · traded 1 April 2015 · filed 6 April 2015
- exercised options over 1,715 shares of Isis PharmaceuticalsSEC Form 420 January 2015Common Stock · traded 15 January 2015 · filed 20 January 2015
- ▼ sold on the open market 903 shares of Isis PharmaceuticalsSEC Form 420 January 2015Common Stock · traded 16 January 2015 · filed 20 January 2015
- exercised options over 2,595 shares of Isis PharmaceuticalsSEC Form 420 January 2015Common Stock · traded 15 January 2015 · filed 20 January 2015
- ▼ sold on the open market 1,372 shares of Isis PharmaceuticalsSEC Form 420 January 2015Common Stock · traded 16 January 2015 · filed 20 January 2015
- exercised options over 3,438 shares of Isis PharmaceuticalsSEC Form 420 January 2015Common Stock · traded 15 January 2015 · filed 20 January 2015
- ▼ sold on the open market 1,818 shares of Isis PharmaceuticalsSEC Form 420 January 2015Common Stock · traded 16 January 2015 · filed 20 January 2015
- was granted 22,076 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 420 January 2015Restricted Stock Units · traded 15 January 2015 · filed 20 January 2015
- exercised options over 1,715 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 420 January 2015Restricted Stock Units · traded 15 January 2015 · filed 20 January 2015
- exercised options over 2,595 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 420 January 2015Restricted Stock Units · traded 15 January 2015 · filed 20 January 2015
- exercised options over 3,438 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 420 January 2015Restricted Stock Units · traded 15 January 2015 · filed 20 January 2015
- acquired or disposed of, other 111 shares of Isis PharmaceuticalsSEC Form 45 January 2015Common Stock · traded 1 January 2015 · filed 5 January 2015
- exercised options over 11,200 shares of Isis PharmaceuticalsSEC Form 45 January 2015Common Stock · traded 2 January 2015 · filed 5 January 2015
- ▼ sold on the open market 11,200 shares of Isis PharmaceuticalsSEC Form 45 January 2015Common Stock · traded 2 January 2015 · filed 5 January 2015
- was granted 132,458 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 45 January 2015Employee Stock Option (right to buy) · traded 2 January 2015 · filed 5 January 2015
- exercised options over 11,200 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 45 January 2015Employee Stock Option (right to buy) · traded 2 January 2015 · filed 5 January 2015
- exercised options over 2,510 shares of Isis PharmaceuticalsSEC Form 431 October 2014Common Stock · traded 30 October 2014 · filed 31 October 2014
- ▼ sold on the open market 2,510 shares of Isis PharmaceuticalsSEC Form 431 October 2014Common Stock · traded 30 October 2014 · filed 31 October 2014
- exercised options over 8,561 shares of Isis PharmaceuticalsSEC Form 431 October 2014Common Stock · traded 30 October 2014 · filed 31 October 2014
- ▼ sold on the open market 8,561 shares of Isis PharmaceuticalsSEC Form 431 October 2014Common Stock · traded 30 October 2014 · filed 31 October 2014
- exercised options over 2,510 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 431 October 2014Employee Stock Option (right to buy) · traded 30 October 2014 · filed 31 October 2014
- exercised options over 8,561 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 431 October 2014Employee Stock Option (right to buy) · traded 30 October 2014 · filed 31 October 2014
- exercised options over 10,628 shares of Isis PharmaceuticalsSEC Form 44 September 2014Common Stock · traded 2 September 2014 · filed 4 September 2014
- ▼ sold on the open market 10,628 shares of Isis PharmaceuticalsSEC Form 44 September 2014Common Stock · traded 2 September 2014 · filed 4 September 2014
- exercised options over 443 shares of Isis PharmaceuticalsSEC Form 44 September 2014Common Stock · traded 2 September 2014 · filed 4 September 2014
- ▼ sold on the open market 443 shares of Isis PharmaceuticalsSEC Form 44 September 2014Common Stock · traded 2 September 2014 · filed 4 September 2014
- exercised options over 10,628 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 44 September 2014Employee Stock Option (right to buy) · traded 2 September 2014 · filed 4 September 2014
- exercised options over 443 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 44 September 2014Employee Stock Option (right to buy) · traded 2 September 2014 · filed 4 September 2014
- acquired or disposed of, other 284 shares of Isis PharmaceuticalsSEC Form 41 July 2014Common Stock · traded 1 July 2014 · filed 1 July 2014
- exercised options over 3,972 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 29 January 2014 · filed 31 January 2014
- ▼ sold on the open market 3,972 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 29 January 2014 · filed 31 January 2014
- exercised options over 31,028 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 29 January 2014 · filed 31 January 2014
- ▼ sold on the open market 31,028 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 29 January 2014 · filed 31 January 2014
- exercised options over 5,000 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 29 January 2014 · filed 31 January 2014
- ▼ sold on the open market 5,000 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 29 January 2014 · filed 31 January 2014
- exercised options over 5,000 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 29 January 2014 · filed 31 January 2014
- ▼ sold on the open market 5,000 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 29 January 2014 · filed 31 January 2014
- exercised options over 5,000 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 29 January 2014 · filed 31 January 2014
- ▼ sold on the open market 5,000 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 29 January 2014 · filed 31 January 2014
- exercised options over 23,635 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 30 January 2014 · filed 31 January 2014
- ▼ sold on the open market 23,635 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 30 January 2014 · filed 31 January 2014
- exercised options over 15,875 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 30 January 2014 · filed 31 January 2014
- ▼ sold on the open market 15,875 shares of Isis PharmaceuticalsSEC Form 431 January 2014Common Stock · traded 30 January 2014 · filed 31 January 2014
- exercised options over 3,972 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 431 January 2014Employee Stock Option (right to buy) · traded 29 January 2014 · filed 31 January 2014
- exercised options over 31,028 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 431 January 2014Employee Stock Option (right to buy) · traded 29 January 2014 · filed 31 January 2014
- exercised options over 5,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 431 January 2014Employee Stock Option (right to buy) · traded 29 January 2014 · filed 31 January 2014
- exercised options over 5,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 431 January 2014Employee Stock Option (right to buy) · traded 29 January 2014 · filed 31 January 2014
- exercised options over 5,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 431 January 2014Employee Stock Option (right to buy) · traded 29 January 2014 · filed 31 January 2014
- exercised options over 23,635 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 431 January 2014Employee Stock Option (right to buy) · traded 30 January 2014 · filed 31 January 2014
- exercised options over 15,875 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 431 January 2014Employee Stock Option (right to buy) · traded 30 January 2014 · filed 31 January 2014
- gave away 5,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 424 January 2014Employee Stock Option (right to buy) · traded 22 January 2014 · filed 24 January 2014
- gave away 5,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 424 January 2014Employee Stock Option (right to buy) · traded 22 January 2014 · filed 24 January 2014
- exercised options over 1,715 shares of Isis PharmaceuticalsSEC Form 417 January 2014Common Stock · traded 15 January 2014 · filed 17 January 2014
- ▼ sold on the open market 653 shares of Isis PharmaceuticalsSEC Form 417 January 2014Common Stock · traded 16 January 2014 · filed 17 January 2014
- exercised options over 2,595 shares of Isis PharmaceuticalsSEC Form 417 January 2014Common Stock · traded 15 January 2014 · filed 17 January 2014
- ▼ sold on the open market 988 shares of Isis PharmaceuticalsSEC Form 417 January 2014Common Stock · traded 16 January 2014 · filed 17 January 2014
- was granted 13,750 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 417 January 2014Restricted Stock Units · traded 15 January 2014 · filed 17 January 2014
- exercised options over 1,715 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 417 January 2014Restricted Stock Units · traded 15 January 2014 · filed 17 January 2014
- exercised options over 2,595 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 417 January 2014Restricted Stock Units · traded 15 January 2014 · filed 17 January 2014
- acquired or disposed of, other 397 shares of Isis PharmaceuticalsSEC Form 43 January 2014Common Stock · traded 1 January 2014 · filed 3 January 2014
- was granted 82,500 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 43 January 2014Employee Stock Option (right to buy) · traded 2 January 2014 · filed 3 January 2014
- gave away 10,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 43 January 2014Employee Stock Option (right to buy) · traded 1 January 2014 · filed 3 January 2014
- gave away 5,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 43 January 2014Employee Stock Option (right to buy) · traded 1 January 2014 · filed 3 January 2014
- gave away 5,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 43 January 2014Employee Stock Option (right to buy) · traded 1 January 2014 · filed 3 January 2014
- exercised options over 37,811 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 430 December 2013Employee Stock Option (right to buy) · traded 26 December 2013 · filed 30 December 2013
- exercised options over 37,811 shares of Isis PharmaceuticalsSEC Form 430 December 2013Common Stock · traded 26 December 2013 · filed 30 December 2013
- ▼ sold on the open market 37,811 shares of Isis PharmaceuticalsSEC Form 430 December 2013Common Stock · traded 26 December 2013 · filed 30 December 2013
- exercised options over 48,229 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 424 December 2013Employee Stock Option (right to buy) · traded 23 December 2013 · filed 24 December 2013
- exercised options over 1,771 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 424 December 2013Employee Stock Option (right to buy) · traded 23 December 2013 · filed 24 December 2013
- exercised options over 20,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 424 December 2013Employee Stock Option (right to buy) · traded 24 December 2013 · filed 24 December 2013
- exercised options over 48,229 shares of Isis PharmaceuticalsSEC Form 424 December 2013Common Stock · traded 23 December 2013 · filed 24 December 2013
- ▼ sold on the open market 48,229 shares of Isis PharmaceuticalsSEC Form 424 December 2013Common Stock · traded 23 December 2013 · filed 24 December 2013
- exercised options over 1,771 shares of Isis PharmaceuticalsSEC Form 424 December 2013Common Stock · traded 23 December 2013 · filed 24 December 2013
- ▼ sold on the open market 1,771 shares of Isis PharmaceuticalsSEC Form 424 December 2013Common Stock · traded 23 December 2013 · filed 24 December 2013
- exercised options over 20,000 shares of Isis PharmaceuticalsSEC Form 424 December 2013Common Stock · traded 24 December 2013 · filed 24 December 2013
- ▼ sold on the open market 20,000 shares of Isis PharmaceuticalsSEC Form 424 December 2013Common Stock · traded 24 December 2013 · filed 24 December 2013
- exercised options over 20,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 423 September 2013Employee Stock Option (right to buy) · traded 19 September 2013 · filed 23 September 2013
- exercised options over 30,000 shares of Isis Pharmaceuticals (a derivative holding)SEC Form 423 September 2013Employee Stock Option (right to buy) · traded 19 September 2013 · filed 23 September 2013
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.